Biomarkers in Multiple Sclerosis (MS) and related disorders: What does the future hold?

Dr Jiwon Oh and Dr Fiona Costello discuss techniques in distinguishing Multiple Sclerosis, and central nervous system disorders that mimic the disease. 

Dr Oh discloses consulting fees or paid advisory boards with Biogen-Idec, BMS, EMD-Serono, Novartis, Roche, Sanofi-Genzyme, and Eli-Lilly. Dr Oh discloses lecture fees or honoraria from speaking at the invitation of Biogen-Idec, EMD-Serono, Roche, Sanofi-Genzyme, and BMS. Dr Oh also discloses current grant support, including non-profit/government entities, from Biogen-Idec, Roche, and EMD-Serono.

Dr Costello discloses consulting fees or paid advisory boards from Alexion, and Frequency Therapeutics. Dr Costello also discloses Lecture fees or honoraria from speaking at the invitation of Novartis, Accure Therapeutics, and Alexion.